You can print a copy from here October 2021 Vol. 2.pdf
or read our newsletter online here.
Head and Neck Cancer News (111)
You can download the file above or read online. See below
You can read and download our Newsletter here.
Click this version to print.
Improved cancer care for Kiwis
SunLive
This week they have released their updated New Zealand Cancer Action Plan, David saying it better reflects the voices of people whose lives are ...
Surveillance of ctDNA in HPV-Positive Head and Neck Cancers May Predict Recurrence
Targeted Oncology
The detection of circulating tumor DNA (ctDNA) in human papillomavirus (HPV) with an experimental blood test has been associated with high positive ...
Potential for new political party as lobby group pushes to increase Pharmac funding
Patient Voice Aotearoa chairman Malcolm Mulholland said the concept of new political entity campaigning for better drug buying policies is gathering support.
Mr Mulholland, whose wife Wiki has terminal cancer, is calling for the doubling of funding to Pharmac.
He said patients with a raft of health issues, ranging from cancer to mental health, are being forced to "beg for their lives" when it comes to acc
Five Steps to a New Normal: Life After Cancer
This article was written by Jenny Leyh, a mother, freelance writer, cancer survivor and integrative health advocate living in Haddon Heights, New Jersey.
Hearing the words “you have cancer” was devastating. It was a life-altering diagnosis that caused time to stand still. But once a plan was established and the treatment began, the fear and unknowns morphed into empowerment. My medical team kept a close eye over everything I did and it was comforting
EU approval for Keytruda in head and neck cancer
The European Commission has approved MSD’s Keytruda (pembrolizumab) as monotherapy or as part of a combination, for the first-line treatment of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC).
The regulatory body says that the approval was based on data from the Phase III KEYNOTE-048 trial, in which the drug, compared with standard treatment (cetuximab with carboplatin or cisplatin plus 5-FU), demo
The Patient Voice Aotearoa chairperson says better medication funding is desperately needed
Eight petitions with 48 thousand signatures were presented to parliament - pleading for money for drugs and devices.
Malcolm Mulholland says the organisation has now decided to lodge their own petition.
He says they are calling on the Government to immediately double the PHARMAC budget with plans to triple it in the future, as well as reform the agency. Read more....
Malcolm Mulholland says the organisation has now decided to lodge their own petition.
He says they are calling on the Government to immediately double the PHARMAC budget with plans to triple it in the future, as well as reform the agency. Read more....
